GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/ Ferroptosis-related genes in small intestinal NETs
70

Ferroptosis-related genes in small intestinal NETs

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2025

The study focused on identifying ferroptosis-related genes in small intestinal neuroendocrine neoplasms (SI-NENs) and their diagnostic and therapeutic potential. Ferroptosis, an iron-dependent cell death mechanism, was analyzed using bioinformatics and machine learning on RNA sequencing datasets (GSE65286 and GSE98894). Researchers identified four key genes: CDCA3, CDC25A, CYP4F8, and MYB, which were experimentally validated using tissue samples from 10 healthy individuals and 14 SI-NEN patients.

Among these genes, CYP4F8 and CDCA3 were significantly downregulated in SI-NEN tumor tissues, suggesting their role as tumor suppressors. Lower expression of these genes was associated with higher tumor grades (G2/G3) and aggressiveness, indicating their potential involvement in tumor progression. Importantly, CYP4F8 showed a strong negative correlation with Ki67 (proliferation marker) and tumor size, linking its reduced expression to increased malignancy.

Gene Set Enrichment Analysis (GSEA) revealed upregulation of cancer-related and metabolic pathways tied to ferroptosis. Functional analysis highlighted pathways like ferroptosis, PPAR signaling, and transcriptional misregulation, which regulate lipid metabolism and oxidative stress. Diagnostic accuracy was demonstrated with Receiver Operating Characteristic (ROC) analysis, showing all four genes had AUC values above 0.9, confirming their potential as biomarkers.

Histological validation confirmed reduced protein levels of CYP4F8 and CDCA3 in SI-NEN tissues. Molecular docking suggested therapeutic potential, with drugs like daunorubicin and quercetin showing strong binding affinity to these genes. Despite promising findings, larger multi-center studies are needed to further validate these genes as biomarkers and therapeutic targets for SI-NENs.

Related Q&A

71

A value of D-dimer in acute arterial mesenteric ischemia

In acute arterial occlusive mesenteric ischemia (AOMI), baseline serum D-dimer levels hold significant prognostic value. The study found that elevated D-dimer levels were strongly associated with both short-term...

72

IBS-Specific IgG ELISA-Based Elimination Diet in IBS

The IBS-specific IgG ELISA-based elimination diet is a personalized dietary intervention designed to address food sensitivities in individuals with irritable bowel syndrome (IBS). This approach leverages an IgG...

73

TEDDY Study - Dietary Supplements, reduces Celiac Disease Risk

The TEDDY study primarily investigated dietary factors, focusing on dietary fiber intake rather than supplements, in relation to celiac disease risk among genetically predisposed children. It followed 6,520...

74

Microbiome-Directed Therapy for Malnutrition

Microbiome-directed therapy for malnutrition represents a groundbreaking approach to addressing childhood undernutrition by targeting the gut microbiome, a critical determinant of health and growth outcomes. Traditional treatments, such...

75

Imaging findings of IBS patients

Imaging studies have revealed several significant findings in patients with irritable bowel syndrome (IBS). These findings span both abdominal and brain imaging, shedding light on the structural and...

76

Microbiota and IBD-C

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of IBS characterized by chronic constipation, abdominal discomfort, and altered bowel habits. The study you referenced explored the relationship between...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer